@dansfera: Big news for heart health! Yesterday, the FDA officially approved Lipfendra (Anlisotide), the first-ever oral PCSK9 inhibitor from Merck. For anyone tracking medical breakthroughs, this is a massive shift—moving a powerful class of cholesterol treatments from painful injections to a simple daily pill. Imagine the liver using little “catcher’s mitts” to regulate cholesterol; this new drug changes the game for how those mitts function. A total revolution in how we handle cardiovascular health. #Cholesterol #HeartHealth #FDAApproval #Merck #MedicalNews

245

There are no more comments for this video.

To see more videos from user @dansfera, please go to the Tikwm homepage.